Nuvectis Pharma, Inc. (NVCT) Tops Q1 EPS by 53c
Tweet
Share
E-mailGet Alerts NVCT Hot Sheet
Join SI Premium – FREE
Nuvectis Pharma, Inc. (NASDAQ: NVCT) reported Q1 EPS of $0.27, $0.53 better than the analyst estimate of ($0.26).
For earnings history and earnings-related data on Nuvectis Pharma, Inc. (NVCT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Upgrades AMD (AMD) to Strong Buy
- Berenberg Starts Jupiter Fund Management (JUP:LN) at Buy
- Macquarie Downgrades Tongcheng Travel Holdings Ltd (780:HK) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
